Lysoway Therapeutics has received a $2.93 million grant from The Michael J. Fox Foundation to advance its TRPML1 agonist for Parkinson's disease treatment.
Amount Raised
$2.93 Million
Round Type
Seed
CambridgeBiotechnologyHealth CareTherapeuticsBiopharmaInvestors
Description
Lysoway Therapeutics, a biopharmaceutical company, announced a research grant from The Michael J. Fox Foundation for Parkinson's Research. The $2.93 million funding will support the development of their TRPML1 agonist. The goal is to initiate first-in-human clinical trials in early 2026
Quick answer
Lysoway Therapeutics raised $2.93 Million in a Seed round, dated August 6, 2025. Investors: The Michael J. Fox Foundation. Lysoway Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Lysoway Therapeutics raise?
- Lysoway Therapeutics raised $2.93 Million in a Seed round on August 6, 2025.
- Who invested in Lysoway Therapeutics?
- The Michael J. Fox Foundation is named as investors in this round.
- What does Lysoway Therapeutics do?
- Lysoway Therapeutics, Inc. is a biopharmaceutical company developing small molecule modulators of lysosomal ion channels.
- Where is Lysoway Therapeutics based and how big is it?
- Lysoway Therapeutics is based in Cambridge, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Lysoway Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $3.8M on September 2, 2025.
- TNF Pharmaceuticals raised $7M on September 2, 2025.
- Retension Pharmaceuticals raised $15M (Series B) on August 6, 2025.
- DiaMedica Therapeutics raised $30M on July 23, 2025.
- DiaMedica Therapeutics raised $30M (Post-IPO Equity) on July 21, 2025.
- GenSight Biologics raised $580K (Seed) on July 17, 2025.
Who to call at Lysoway Therapeutics, and when
A new round usually means Lysoway Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lysoway Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lysoway Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lysoway Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lysoway Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Lysoway Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.